Tuesday, January 25, 2022 2:00 pm-3:00 pm Eastern
This interactive live webinar is part 8 of the Emerging and Evolving Biomarkers Series.
Description:
DNA methylation plays an essential role in regulating gene transcription and cell fate. Both normal tissues and neoplasms have unique genome-wide methylation signatures that can be interrogated using modern molecular techniques. This presentation will describe the clinical applications of genome-wide DNA methylation profiling and its emerging role as a tumor biomarker. Emphasis will be placed on how DNA methylation profiling can refine tumor classification schemes and be utilized as a clinical diagnostic for molecular tumor classification.
Learning Objectives:
-
Describe the basic biology of DNA methylation and the specific technologies used to detect DNA methylation in the clinical environment.
-
Describe how methylation profiling can be used as a clinical diagnostic in the molecular pathology laboratory.
-
Describe how tumor classification schemes can be refined using unsupervised methylation profiling.
 |
 |
|---|---|
|
Speaker:
Brent A. Orr MD, PhD |
Moderator: Anthony Snow, MD |
Duration: 1 Hour
This program has been supported through educational grant funding provided by Amgen and Loxo Oncology at Lilly (for further information concerning Lilly grant funding visit www.lillygrantoffice.com.) Supporting companies had no control over its content. No personally-identifiable information regarding you is provided to any grant supporters.
- Click the "Register Now" Button
- Log in using your AMP credentials. If you do not have an AMP account, Create a FREE account by clicking here.
- Complete the "Demographic questionnaire for Emerging and Evolving Biomarkers Series" before the webinar date. You will only need to do this once for the entire series.
Continuing Education Credit Information
CME credit: 1.0CMLE credit: 1.0
Last day to claim credit: February 25, 2022
Accreditation Statements
AMA PRA Category 1 Credit(s)™
This
activity has been planned and implemented in accordance with the
Essential Areas and policies of the Accreditation Council for Continuing
Medical Education through the joint providership of American Society
for Clinical Pathology (ASCP) and Association for Molecular Pathology
(AMP). The American Society for Clinical Pathology (ASCP) is accredited
by the ACCME to provide continuing medical education for physicians.
The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
CMLE
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours
of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP
Board of Certification (BOC) Certification Maintenance Program
(CMP). CMLE credit hours meet the continuing education requirements for
the ASCP Board of Certification Credential Maintenance Program (CMP) and
state relicensure requirements for laboratory personnel. Participants
should claim only the credit commensurate with the extent of their
participation in the activity.
.jpg){kind=small}
AMP is pleased to collaborate in the Immunotherapy Collaborative of Oncology Networked Communities, IC-ONC. IC-ONC is a global information network in which multidisciplinary healthcare providers, responsible for treating patients with cancer, are connected via education.
Please be sure to visit www.ic-onc.org to learn more about the collaborative and all it has to offer.
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation
